Vestnik dermatologii i venerologiiVestnik dermatologii i venerologiiВестник дерматологии и венерологии0042-46092313-6294Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov10210.25208/0042-4609-2015-91-1-32-40EDITORIALРедакционная статьяPhotodynamic therapy with methyl aminolevulinate in the treatment of basal cell carcinomaПрименение метиламинолевулината в фотодинамической терапии больных с базальноклеточным раком кожиKubanovA. A.КубановА. А.
Russian Federation
KondrakhinaI. N.КондрахинаИ. Н.
Russian Federation
GribanovN. V.ГрибановН. В.
Russian Federation
gribanov@cnikvi.ruState Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian FederationФГБУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава России24022015911324024082017Copyright ©; 2015, Kubanov A.A., Kondrakhina I.N., Gribanov N.V.Copyright ©; 2015, Кубанов А.А., Кондрахина И.Н., Грибанов Н.В.2015Kubanov A.A., Kondrakhina I.N., Gribanov N.V.Кубанов А.А., Кондрахина И.Н., Грибанов Н.В.https://creativecommons.org/licenses/by/4.0https://vestnikdv.ru/jour/article/view/102

The article presents the results of the studies on the effectiveness of treatment basal cell carcinoma of the skin with photodynamic therapy with 5-aminolevulinic acid and methyl aminolevulinate. The results of the comparing trials between photodynamic therapy with methyl aminolevulinate and different other treatment modalities are presented.

Проанализированы результаты исследований эффективности, частоты рецидивирования и эстетических последствий применения 5-аминолевулиновой кислоты и метиламинолевулината в фотодинамической терапии больных с базальноклеточным раком кожи.

фотодинамическая терапия5-аминолевулиновая кислотаметиламинолевулинатбазальноклеточный рак кожиphotodynamic therapy5-aminolevulinic acidmethyl aminolevulinatebasal cell carcinomaFilonenko E.V. Fizicheskie metody v lechenii bol'nyh rakom kozhi. Medicinskie tehnologii. Ocenka i vybor 2012; 2: 100-105.Vejshner Ju.L. Statisticheskie dannye po Rossii po onkologicheskim zabolevanijam sredi naselenija 2010.Molochkov V.A., Mardi Sh. Novye podhody k lecheniju nemelanoticheskogo raka kozhi 2007; Al'manah klinicheskoj mediciny 2007; 15: 235-237.Kulagin V.I., Ponomarev B.A., Selisskij G.D. s soavt. Aktual'nye problemy sovershenstvovanija specializirovannoj pomoshhi bol'nym dermatozami. Ross zhurn kozhn venerich zabolevanij 2001; 6: 57-59.Shental' V.V., Malaev S.G., Pustynskij I.N. Rak kozhi. Medicinskaja pomoshh' 2000; 46: 10.Galil-Ogly G.A., Molochkov V.A., Sergeev Ju.V., Dermatoonkologija. M: Medicina dlja vseh 2005; 872.Indilova I. Lazernaja konfokal'naja mikroskopija v diagnostike i ocenke jeffektivnosti metodov lechenija bazal'no-kletochnogo raka kozhi. Jeksperi klini dermatokosmetol 2011; 4: 54-63.McCusker M., Basset-Seguin N., Dummer R. et al. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer 2014; 50 (4): 774-783.Danial C., Lingala B., Balise R., Oro A.E. et al. Br J Dermatol. Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma 2013; 169 (3): 673-676.V.N. Volgin, T.V. Sokolova, M.S. Kolbina, A.A. Sokolovskaya. Basalioma: Epidemiology, etiology, pathogenesis and clinical picture (part 1).V.N. Volgin, T.V. Sokolova, M.S. Kolbina, A.A. Sokolovskaya. Basalioma (part 2).B.A. Berenbejn, A.A. Studnicin. Differencial'naja diagnostika kozhnyh boleznej. 2-e izd. M: Medicina 1989.Cigna E., Tarallo M., Maruccia M. et al. Basal cell carcinoma: 10 years of experience. J Skin Cancer 2011;2011:476362.Roozeboom M.H., Arits A.H., Nelemans P.J., Kelleners-Smeets N.W. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol. 2012; 167 (4): 733-756.Clark C.M., Furniss M., Mackay-Wiggan J.M. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol 2014; 15 (3): 197-216.Bahner J.D., Bordeaux J.S. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin Dermatol 2013; 31 (6): 792-798.Bath-Hextall F.J., Perkins W., Bong J., Williams H.C. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007; 24.Dieu T., Macleod A.M. Incomplete excision of basal cell carcinomas: a retrospective audit. ANZ J Surg. 2002; 72 (3): 219-221.Nagore E., Grau C., Molinero J., Fortea J.M. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol. 2003; 17 (2): 167-170.Sokolova T.V, Volgin V.N. Jekonomicheskaja i klinicheskaja ocenka jeffektivnosti fotodinamicheskoj terapii bazal'no-kletochnogo raka kozhi. Ros zhurn kozhn venerich bol 2009; 2: 15-18.Ceilley R.I., Del Rosso J.Q. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol. 2006; 45 (5): 489-498.Mosterd K., Krekels G.A., Nieman F.H. et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9 (12): 1149-1156.Marghoob A., Kopf A.W., Bart R.S. et al. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol. 1993; 28 (1): 22-28.Chissov V.I. Algoritmy objomov diagnostiki i lechenija zlokachestvennyh novoobrazovanij: metodicheskie ukazanija. M, 2002.Kolbina M.S., Sokolova T.V., Volgin V.N. Metod mestnogo obezbolivanija pri fotodinamicheskoj terapii bazal'nokletochnogo raka kozhi s applikacionnym naneseniem fotosensibilizatora. Klini dermatol venerol 2012; 4: 90-93.Pisklakova T.P., Il’in I.I. K voprosu ob effektivnosti lechenija bazaliomy kozhi. Vestn dermatol 1990; 6: 66-67.Ceilley R.I., Del Rosso J.Q. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol 2006; 45 (5): 489-498.Silverman M.K., Kopf A.W., Gladstein A.H., et al. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992; 18 (7): 549-554.Kunte C., Konz B. Current recommendations in the treatment of basal cell carcinoma and squamous cell carcinoma of the skin. Hautarzt 2007; 58 (5): 419-426.Martin H., Strong E., Spiro R.H. Radiation-induced skin cancer of the head and neck. Cancer. 1970; 25 (1): 61-71.Shajn A.A. Onkologija. М: Akademija, 2004. 544.Petit J.Y., Avril M.F., Margulis A. et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000; 105 (7): 2544-2551.Kolbina M.S. Jeffektivnost' fotodinamicheskoj terapii bazal'no-kletochnogo raka kozhi s naneseniem applikacionnoj formy fotoditazina i ocenka otdalennyh rezul'tatov lechenija. Ros nauchn zhurn 2010; 6: 25-28.Pottier R., Krammer B., Baumgartner R. Photodynamic Therapy with ALA: A Clinical Handbook 2006. 13; 276.Thissen M.R., Neumann M.H., Schouten L.J. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 135 (10): 1177-1183.Thissen M.R., Nieman F.H., Ideler A.H. et al. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000; 26 (8): 759-764.Jaroslavceva-Isaeva E.V., Kaplan M.A., Romanko Ju.S., Sokol N.I. Razrabotka metodiki fotodinamicheskoj terapii jeksperimental'noj opuholi (sarkoma M-1) pri lokal'nom vvedenii fotosensibilizatora. Ros bioterapevtich zhurn 2003; 2 (4): 19-22.Gelfond M.L. Fotodinamicheskaja terapija v onkologii. Praktich onkol 2007; 8 (4): 204- 210.Suhova T.E., Molochkov V.A., Romanko Ju.S., Changljan K.A., Tret'jakova E.I. Fotodinamicheskaja terapija aktinicheskogo keratoza s applikacionnym primeneniem Fotoditazina. Ros zhurn kozhn vener bol 2010; 5: 4-8.Suhova T.E., Molochkov V.A., Romanko Ju.S., s soavt. Lechenie bazal'nokletochnogo raka kozhi na sovremennom jetape. Al'manah klinicheskoj mediciny 2008; 18: 13-24Cyb A.F., Kaplan M.A., Romanko Ju.S., Popuchiev V.V. Fotodinamicheskaja terapija. Moskva: OOO Medicinskoe informacionnoe agentstvo; 2009.Boyle R.W., Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 1996; 64 (3): 469-485.Calzavara-Pinton P.G., Venturini M., Sala R. Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology. J Eur Acad Dermatol Venereol. 2007; 21 (3): 293-302.Gold M.H., Goldman M.P. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg. 2004; 30 (8): 1077-1083.Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6 (1-2): 143-148.Fritsch C., Homey B., Stahl W. et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol. 1998; 68 (2): 218-221.Ackermann G., Abels C., Baumler W. et al. Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo. J Photochem Photobiol B. 1998; 47 (2-3): 121-128.Szeimes R.M., Karrer S., Abels C. et al. Photochemotherapy of cutaneous AIDS-associated Kaposi sarcoma with indocyanine green and laser light. Hautarzt 2001; 52 (4): 322-236.Boehncke W.H., Konig K., Ruck A., et al. In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma. Acta Derm Venereol. 1994; 74 (3): 201-205.Morton C.A., Brown S.B., Collins S., et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146 (4): 552-567.Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990; 6 (1-2): 143-148.Morton C.A., Whitehurst C., Moore J.V. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001 Mar; 137 (3): 319-324.Clark C., Bryden A., Dawe R. et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003; 19 (3): 134-141.Wang I., Bendsoe N., Klinteberg C.A. et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144 (4): 832-840.Peng Q., Warloe T., Berk K. et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. 1997. Cancer 1997; 79 (12): 2282-2308.Morton C.A., Whitehurst C., Moore J.V. et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143 (4): 767-772.Fotinos N., Campo M.A., Popowycz F. et al. 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives. Photochem Photobiol 2006; 82 (4): 994-1015.Moan J., Ma L.W., Iani V. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer 2001; 92 (1): 139-143.Casas A., Fukuda H., Di Venosa G., Batlle A. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer 2001; 85 (2): 279-284.Gaullier J.M., Berg K., Peng Q. et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 1997; 57 (8): 1481-1486.Fritsch C., Homey B., Stahl W., et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol 1998; 68 (2): 218-221.Juzenas P., Sharfaei S., Moan J., Bissonnette R. Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevu-linic acid methyl ester. J Photochem Photobiol B 2002; 67 (1): 11-17.Moan J., Ma L.W., Juzeniene A. et al. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int J Cancer 2003; 103 (1): 132-135.Basset-Seguin N., Bachmann I., Pavel S. et al. A dosefinding study of photodynamic therapy (PDT) with Metvix® in patients with basal cell carcinoma (BCC). 2000; European Academy of Dermatology and venerology. 1, 39.Soler A.M., Warloe T., Berner A., Giercksky K.E. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001; 145 (3): 467-471.Horn M., Wolf P., Wulf H.C. et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149: 1242-1249.Ramirez D.P., Kurachi C., Inada N.M. et al. Experience and BCC subtypes as determinants of MAL-PDT response: Preliminary results of a national Brazilian project. Photodiagnosis Photodyn Ther 2013; 10 (4): 703-709.Rhodes L.E., De Rie M., Enstrom Y. et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140 (1): 17-23.Basset-Séguin N., Ibbotson S., Emtestam L. et al. Photodynamic therapy using methyl amino-laevulinate is as efficacious as cryotherapy in basal cell carcinoma, with better cosmetic results. Br J Dermatol 2003; 149: 46.Fantini F., Greco A., Del Giovane C. et al. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol 2011; 25 (8): 896-901.Braathen L., Paredes B., Frolich K. et al. A dose finding study of photodynamic therapy (PDT) with Metvix in actinic keratosis (AK). J Eur Acad Dermatol 2000; 14: 38.Pariser D.M., Lowe N.J., Stewart D.M. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2008; 59 (4): 569-576.Foley P., Freeman M., Siller G. et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48 (2): 227-232.Tope W.D., Menter A., El-Azhary R.A. et al. Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma. J Am Acad Dermatol 2004; 50 (3): 123.Morton C.A., Szemies R.M., Braathen L.R. Update on topical photodynamic therapy for skin cancer. Vestn dermatol venerol 2014; 6: 26-34.Guideline Subcommittee "Basal Cell Carcinoma" of the European Dermatology Forum. Update of the Guideline on Basal Cell Carcinoma. http://www.euroderm.org/images/stories/ guidelines/guideline_Basal_Cell_Carcinoma-update2012%20.pdf